UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lubricin/proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis

Osteoarthritis and cartilage, 2017-01, Vol.25 (1), p.128-137

2017

Volltextzugriff (PDF)

Lubricin in experimental and naturally occurring osteoarthritis: a systematic review

Osteoarthritis and cartilage, 2020-10, Vol.28 (10), p.1303-1315

2020

Volltextzugriff (PDF)

Synovial fluid lubricin increases in canine cruciate ligament rupture

Osteoarthritis and cartilage, 2019-04, Vol.27, p.S470-S471

2019

Volltextzugriff (PDF)

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

Scandinavian journal of gastroenterology, 2012-04, Vol.47 (4), p.475-481

2012

Volltextzugriff (PDF)

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

Journal of medical virology, 2009-06, Vol.81 (6), p.988-995

2009

Volltextzugriff (PDF)

P182 VIRAL PARTICLES CONTAINING HBVRNA ARE PRESENT IN PLASMA BEFORE AND DURING NUCLEOS(T)IDE ANALOGUE TREATMENT OF CHRONIC HEPATITIS B PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S127-S127

2014

Volltextzugriff (PDF)

P684 PLASMA HBV RNA AS BASELINE PREDICTOR OF RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON AND ADEFOVIR

Journal of hepatology, 2014-04, Vol.60 (1), p.S297-S297

2014

Volltextzugriff (PDF)

LP29 : A randomised prospective open-label trial comparing peginterferon + adefovir and peginterferon + tenofovir versus no treatment in hbeag negative chronic hepatitis b patients with low viral load: analysis of week 48 results

Journal of hepatology, 2015-04, Vol.62, p.S278-S279

2015

Volltextzugriff (PDF)

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

Journal of medical virology, 2009-03, Vol.81 (3), p.413-416

2009

Volltextzugriff (PDF)

P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir

Journal of hepatology, 2015-04, Vol.62, p.S498-S498

2015

Volltextzugriff (PDF)

411 A NEW HBsAg/ANTI-HBs IMMUNE COMPLEX ASSAY PREDICTS HBeAG LOSS IN CHRONIC HEPATITIS B PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S168-S169

2013

Volltextzugriff (PDF)

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

Journal of hepatology, 2013-04, Vol.58, p.S305-S305

2013

Volltextzugriff (PDF)

415 SNP rs12356193 AND PLASMA CARNITINE LEVELS ARE ASSOCIATED WITH HBsAg LOSS AFTER COMBINATION TREATMENT WITH PEGINTERFERON AND ADEFOVIR

Journal of hepatology, 2013-04, Vol.58, p.S170-S170

2013

Volltextzugriff (PDF)

Reliability of polymerase chain reaction for detection of hepatitis C virus

The Lancet (British edition), 1993-03, Vol.341 (8847), p.722-724

1993

Volltextzugriff (PDF)

O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients

Journal of clinical virology, 2009, Vol.44, p.S5-S5

2009

Volltextzugriff (PDF)

O.1.2 Hepatitis B susceptibility to lamivudine restored by resistance to adefovir

Journal of clinical virology, 2009, Vol.44, p.S5-S5

2009

Volltextzugriff (PDF)

International collaborative study on the second EUROHEP HCV-RNA reference panel

Journal of virological methods, 1996-04, Vol.58 (1), p.175-185

1996

Volltextzugriff (PDF)

P1884 Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients

International journal of antimicrobial agents, 2007, Vol.29, p.S540-S540

2007

Volltextzugriff (PDF)

P1885 Similar early viral kinetics of hepatitis C virus genotypes 1 and 4

International journal of antimicrobial agents, 2007, Vol.29, p.S540-S540

2007

Volltextzugriff (PDF)

P.249 Recurrence or persistence of HCV RNA detectable only by TMA during antiviral therapy

Journal of clinical virology, 2006, Vol.36, p.S139-S139

2006

Volltextzugriff (PDF)

Look-back study of infectivity of anti-HCV ELISA-positive blood components

The Lancet (British edition), 1995-01, Vol.345 (8942), p.95-96

1995

Volltextzugriff (PDF)

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus

Transfusion (Philadelphia, Pa.), 1995-09, Vol.35 (9), p.745-749

1995

Volltextzugriff (PDF)

Transmission of Hepatitis C Virus by Anti‐HCV‐Negative Blood Transfusion: Case Report

Vox sanguinis, 1995-01, Vol.68 (1), p.55-56

1995

Volltextzugriff (PDF)

Sensitivity and Specificity of Three Third-Generation Anti-Hepatitis C Virus ELISAs

Vox sanguinis, 1995-07, Vol.69 (1), p.14-17

1995

Volltextzugriff (PDF)

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients

Transfusion (Philadelphia, Pa.), 1993-08, Vol.33 (8), p.634-638

1993

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(38)
Berichte
(1)

Sprache

Englisch
(38)
Spanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lubricin/proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis

Lubricin in experimental and naturally occurring osteoarthritis: a systematic review

Synovial fluid lubricin increases in canine cruciate ligament rupture

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

P182 VIRAL PARTICLES CONTAINING HBVRNA ARE PRESENT IN PLASMA BEFORE AND DURING NUCLEOS(T)IDE ANALOGUE TREATMENT OF CHRONIC HEPATITIS B PATIENTS

P684 PLASMA HBV RNA AS BASELINE PREDICTOR OF RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON AND ADEFOVIR

LP29 : A randomised prospective open-label trial comparing peginterferon + adefovir and peginterferon + tenofovir versus no treatment in hbeag negative chronic hepatitis b patients with low viral load: analysis of week 48 results

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir

411 A NEW HBsAg/ANTI-HBs IMMUNE COMPLEX ASSAY PREDICTS HBeAG LOSS IN CHRONIC HEPATITIS B PATIENTS

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

415 SNP rs12356193 AND PLASMA CARNITINE LEVELS ARE ASSOCIATED WITH HBsAg LOSS AFTER COMBINATION TREATMENT WITH PEGINTERFERON AND ADEFOVIR

Reliability of polymerase chain reaction for detection of hepatitis C virus

O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients

O.1.2 Hepatitis B susceptibility to lamivudine restored by resistance to adefovir

International collaborative study on the second EUROHEP HCV-RNA reference panel

P1884 Early prediction of response during high-dose interferon induction therapy in difficult-to-treat chronic hepatitis C patients

P1885 Similar early viral kinetics of hepatitis C virus genotypes 1 and 4

P.249 Recurrence or persistence of HCV RNA detectable only by TMA during antiviral therapy

Look-back study of infectivity of anti-HCV ELISA-positive blood components

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus

Transmission of Hepatitis C Virus by Anti‐HCV‐Negative Blood Transfusion: Case Report

Sensitivity and Specificity of Three Third-Generation Anti-Hepatitis C Virus ELISAs

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients

Suchergebnisse filtern